+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Liquid Biopsy Market Analysis & Forecast 2024-2034: Market By Sample; By Biomarker; By Product; By Technology (Single Gene Analysis, Multi-gene-parallel Analysis; By Application; By Clinical Applications; By End-user; and By Region

  • PDF Icon

    Report

  • 145 Pages
  • October 2023
  • Region: Global
  • Erevna Healthcare
  • ID: 5890344
The global liquid biopsy market size was estimated to be USD 10.15 billion in 2023 and is expected to reach at USD 40.95 billion by 2034 with a CAGR of 13.52% during the forecast period 2024-2034. Increasing prevalence of oncology disorders, growing preference for minimally invasive diagnostics, rising geriatric population, surge in number of clinical trials for the development of novel liquid biopsy assays, increasing technological advancements, and rising investment by major market players for the development of new tests are some of the key factors boosting the market growth.

Rising investment by major market players for the development of new tests is predicted to boost the market growth during the forecast period. Precision oncology's fast developing liquid biopsy technique allows for least invasive molecular diagnosis and longitudinal monitoring for therapeutic objectives. In clinical practice, the quantification and detection of circulating DNA are now often utilized to treat advanced-stage lung cancer. Clinical studies now have new avenues to explore because of liquid biopsy technology, which is providing an additional source for cancer biomarkers. For instance, in July 2022, A MCED test that is both simple to use and effective was developed by Delfi Diagnostics, Inc. with $225 million in financing. The company is working on reducing the test's price to ensure it becomes more widely accessible to the general public.

By sample, blood sample was the highest revenue-grossing segment in the global liquid biopsy market in 2023 owing to the rising products approvals by regulatory bodies such as Guardant360 CDx & FoundationOne Liquid CDx that require blood samples for testing and increasing launch of new products. Additionally, others is predicted to grow at fastest CAGR during the forecast period owing to the increasing adoption of urine-based biopsy, growing launch of novel. For instance, in March 2022, miR Scientific, LLC unveiled their urine-sample-based liquid biopsy tests in the South East Asia and Singapore regions. Subsequently, the test was officially released for commercial use in the United States in July 2022.

By biomarker, circulating tumor cells (CTCs) biomarker was the highest revenue-grossing segment in the global liquid biopsy market in 2023 owing to its usage as a key biomarker for the early identification of cancer in molecular tests, presence of novel products that detect CTC, and increasing regulatory approvals. Additionally, circulating tumor DNA (ctDNA) is predicted to grow at fastest CAGR during the forecast period owing to the increasing demand for cancer diagnosis, rising funding by government for the development of advanced test kits, and growing initiatives by market players. For instance, in May 2022, Cancer screening services using blood samples will now be offered across Europe, according to Guardant Health Inc. These services are now in operation at the liquid biopsy testing facility of the Vall d'Hebron Institute of Oncology (VHIO) located in Barcelona.

By product, instruments was the highest revenue-grossing segment in the global liquid biopsy market in 2023 owing to the growing launch of advanced instruments and the advancement of existing products. For instance, in June 2022, Tempus has expanded its range of comprehensive genomic profiling services by introducing xF+, a novel liquid biopsy panel comprised of 523 genes. This new non-invasive test specifically targets pathogenic mutations in cell-free DNA (cfDNA). Additionally, consumbale kits & reagents is predicted to grow at fastest CAGR during the forecast period owing to the growing research & development activities by key market players for the development of advanced kits & reagents.

By technology, multi-gene-parallel analysis (NGS) was the highest revenue-grossing segment in the global liquid biopsy market in 2023 owing to the rising developments in NGS technology, increasing demand for sequencing of millions of different DNA molecules, and surge in introduction of various innovative products. For instance, in August 2022, Thermo Fisher Scientific Inc. has introduced the inaugural Next-Generation Sequencing (NGS) test capable of accommodating both DNA and RNA input. The Ion Torrent Oncomine Myeloid MRD Assays (ROU) offer a comprehensive and exceptionally sensitive assessment of measurable residual myeloid (MDR) presence in blood and bone marrow samples. Additionally, single gene analysis (PCR microarrays) is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of genetic disorders, rising focus on early diagnosis, and increasing research & development activities.

By application, cancer was the highest revenue-grossing segment in the global liquid biopsy market in 2023 owing to the growing prevalence of cancer, rising usage of liquid biopsy in screening its various forms, increasing research & development activities, and surge in launch of innovative systems. For instance, in November 2022, Thermo Fisher Scientific has launched digital PCR liquid-biopsy assays for its Applied Biosystems absolute Q dPCR system, alongside a custom design tool aimed at streamlining cancer research for academic and clinical research institutions. Additionally, reproductive health is predicted to grow at fastest CAGR during the forecast period owing to the increasing research & development activities in the field of liquid biopsy being taken into consideration for treating and maintaining reproductive health, surge in collaborations & partnerships within market players in the field of reproductive healthz.

By clinical applications, therapy selection was the highest revenue-grossing segment in the global liquid biopsy market in 2023 owing to the rising impact on the treatment regimens used to enhance patient outcomes, growing use of liquid biopsies can improve cancer therapies by enabling early intervention, enhancing treatment control, & moving the focus of decision-making from reactive actions to more proactive early interventions. Additionally, early cancer screening is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of cancer, surge in need to provide efficient methods for early detection of cancer, increasing research to develop & commercialize early screening tests by adopting the liquid biopsy technique, and rising launch of new products. For instance, in May 2022, The therascreen EGFR Plus RGQ PCR Kit, a novel in vitro diagnostic test for sensitive EGFR mutation analysis, was introduced by QIAGEN N.V.

By end-user, hospitals & laboratories was the highest revenue-grossing segment in the global liquid biopsy market in 2023 owing to the wide range of applications of liquid biopsy in hospitals for early screening & diagnosis of cancer patients, growing outsourcing activities for tests, and increasing launch of diagnostic platforms. For instance, in July 2022., Nanostics Inc. revealed the initiation of a validation study for their ClarityDX diagnostic platform, a clinical investigation of a noninvasive liquid biopsy test designed to detect bladder cancer. Additionally, academic & research centers is predicted to grow at fastest CAGR during the forecast period owing to the increasing research in the field of cancer detection, growing number of research & academic centers, surge in investment for research activities, and rising focus on development of liquid biopsy products in research centers.

North America region is anticipated for the highest revenue share during the forecast period owing to the surge in prevalence of cancer, growing technological advancements, rising government initiatives, increasing FDA approvals for liquid biopsy tests, and surge partnership & collaborations within market players. For instance, in June 2022, F. Hoffmann-La Roche Ltd has collaborated with the Lung Cancer Research Foundation (LCRF) and the Lung Cancer Mutation Consortium (LCMC) to take part in the LCMC 4th screening trial. This trial aims to assess identifiable factors in the early stages of lung cancer with the goal of providing targeted therapy options for patients. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing healthcare infrastructure, rising usage of screening tests for cancer, growing government initiatives such as free screening for cervical, breast, & lung cancer, surge in collaborations between governments, research institutes, & companies, and increasing launch of novel products. For instance, in June 2023, Labcorp has introduced the Plasma Focus test, a liquid biopsy designed to identify biomarkers associated with cancers.

Segmentation: Liquid Biopsy Market Report 2022 - 2033

Liquid Biopsy Market Analysis & Forecast by Sample 2022 - 2033 (Revenue USD Bn)

  • Blood Sample
  • Others

Liquid Biopsy Market Analysis & Forecast by Biomarker 2022 - 2033 (Revenue USD Bn)

  • Circulating Tumor DNA (ctDNA)
  • Extracellular Vesicles (EVs)
  • Circulating Tumor Cells (CTCs)
  • Others

Liquid Biopsy Market Analysis & Forecast by Product 2022 - 2033 (Revenue USD Bn)

  • Consumables Kits & Reagents
  • Instruments
  • Software and Services

Liquid Biopsy Market Analysis & Forecast by Technology 2022 - 2033 (Revenue USD Bn)

  • Single Gene Analysis (PCR Microarrays)
  • Multi-gene-parallel Analysis (NGS))

Liquid Biopsy Market Analysis & Forecast by Application 2022 - 2033 (Revenue USD Bn)

  • Reproductive Health
  • Cancer
  • Breast Cancer
  • Leukemia
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Gastrointestinal Cancer
  • Others

Liquid Biopsy Market Analysis & Forecast by Clinical Applications 2022 - 2033 (Revenue USD Bn)

  • Early Cancer Screening
  • Therapy Selection
  • Recurrence Monitoring
  • Treatment Monitoring
  • Others

Liquid Biopsy Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Bn)

  • Academic & Research Centers
  • Hospitals & Laboratories
  • Specialty Clinics
  • Others

Liquid Biopsy Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Bn)

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Liquid Biopsy Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Liquid Biopsy Market: Sample Estimates & Trend Analysis
7.1. Sample Segment Opportunity Analysis
7.2. Blood Sample
7.2.1. Blood Sample Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Others
7.3.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Liquid Biopsy Market: Biomarker Estimates & Trend Analysis
8.1. Biomarker Segment Opportunity Analysis
8.2. Circulating Tumor DNA (ctDNA)
8.2.1. Circulating Tumor DNA (ctDNA) Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Extracellular Vesicles (EVs)
8.3.1. Extracellular Vesicles (EVs) Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Circulating Tumor Cells (CTCs)
8.4.1. Circulating Tumor Cells (CTCs) Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.5. Others
8.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Liquid Biopsy Market: Product Estimates & Trend Analysis
9.1. Product Segment Opportunity Analysis
9.2. Consumables Kits & Reagents
9.2.1. Consumables Kits & Reagents Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Instruments
9.3.1. Instruments Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Software and Services
9.4.1. Software and Services Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Liquid Biopsy Market: Technology Estimates & Trend Analysis
10.1. Technology Segment Opportunity Analysis
10.2. Single Gene Analysis (PCR Microarrays)
10.2.1. Single Gene Analysis (PCR Microarrays) Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.3. Multi-gene-parallel Analysis (NGS))
10.3.1. Multi-gene-parallel Analysis (NGS)) Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11. Liquid Biopsy Market: Application Estimates & Trend Analysis
11.1. Application Segment Opportunity Analysis
11.2. Reproductive Health
11.2.1. Reproductive Health Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11.3. Cancer
11.3.1. Cancer Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11.3.2. Breast Cancer
11.3.2.1. Breast Cancer Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11.3.3. Leukemia
11.3.3.1. Leukemia Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11.3.4. Lung Cancer
11.3.4.1. Lung Cancer Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11.3.5. Colorectal Cancer
11.3.5.1. Colorectal Cancer Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11.3.6. Prostate Cancer
11.3.6.1. Prostate Cancer Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11.3.7. Gastrointestinal Cancer
11.3.7.1. Gastrointestinal Cancer Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11.3.8. Others
11.3.8.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11.4. Others
11.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
12. Liquid Biopsy Market: Clinical Application Estimates & Trend Analysis
12.1. Clinical Application Segment Opportunity Analysis
12.2. Early Cancer Screening
12.2.1.1. Early Cancer Screening Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
12.3. Therapy Selection
12.3.1.1. Therapy Selection Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
12.4. Recurrence Monitoring
12.4.1.1. Recurrence Monitoring Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
12.5. Treatment Monitoring
12.5.1.1. Treatment Monitoring Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
12.6. Others
12.6.1.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
13. Liquid Biopsy Market: End-user Estimates & Trend Analysis
13.1. End-user Segment Opportunity Analysis
13.2. Academic & Research Centers
13.2.1.1. Academic & Research Centers Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
13.3. Hospitals & Laboratories
13.3.1.1. Hospitals & Laboratories Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
13.4. Specialty Clinics
13.4.1.1. Specialty Clinics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
13.5. Others
13.5.1.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
14. Regional Market Analysis
14.1. Regional Market Opportunity Analysis
15. North America Liquid Biopsy Market
15.1. North America Liquid Biopsy Market
15.1.1. North America Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. North America Liquid Biopsy Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. North America Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
15.1.4. North America Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
15.1.5. North America Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
15.1.6. North America Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
15.1.7. North America Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.1.8. North America Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
15.1.9. North America Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.2. U.S. Global Liquid Biopsy Market
15.2.1. U.S. Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. U.S. Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
15.2.3. U.S. Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
15.2.4. U.S. Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
15.2.5. U.S. Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
15.2.6. U.S. Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.2.7. U.S. Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
15.2.8. U.S. Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.3. Canada Global Liquid Biopsy Market
15.3.1. Canada Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. Canada Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
15.3.3. Canada Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
15.3.4. Canada Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
15.3.5. Canada Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
15.3.6. Canada Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.3.7. Canada Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
15.3.8. Canada Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16. Europe Global Liquid Biopsy Market
16.1. Europe Global Liquid Biopsy Market
16.1.1. Europe Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.1.2. Europe Liquid Biopsy Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
16.1.3. Europe Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
16.1.4. Europe Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
16.1.5. Europe Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
16.1.6. Europe Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
16.1.7. Europe Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
16.1.8. Europe Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
16.1.9. Europe Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.2. Germany Global Liquid Biopsy Market
16.2.1. Germany Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.2.2. Germany Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
16.2.3. Germany Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
16.2.4. Germany Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
16.2.5. Germany Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
16.2.6. Germany Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
16.2.7. Germany Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
16.2.8. Germany Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.3. UK Global Liquid Biopsy Market
16.3.1. UK Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.3.2. UK Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
16.3.3. UK Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
16.3.4. UK Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
16.3.5. UK Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
16.3.6. UK Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
16.3.7. UK Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
16.3.8. UK Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.4. France Global Liquid Biopsy Market
16.4.1. France Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.4.2. France Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
16.4.3. France Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
16.4.4. France Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
16.4.5. France Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
16.4.6. France Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
16.4.7. France Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
16.4.8. France Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.5. Spain Global Liquid Biopsy Market
16.5.1. Spain Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.5.2. Spain Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
16.5.3. Spain Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
16.5.4. Spain Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
16.5.5. Spain Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
16.5.6. Spain Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
16.5.7. Spain Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
16.5.8. Spain Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.6. Italy Global Liquid Biopsy Market
16.6.1. Italy Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.6.2. Italy Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
16.6.3. Italy Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
16.6.4. Italy Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
16.6.5. Italy Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
16.6.6. Italy Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
16.6.7. Italy Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
16.6.8. Italy Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16.7. Rest of Europe Global Liquid Biopsy Market
16.7.1. Rest of Europe Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.7.2. Rest of Europe Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
16.7.3. Rest of Europe Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
16.7.4. Rest of Europe Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
16.7.5. Rest of Europe Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
16.7.6. Rest of Europe Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
16.7.7. Rest of Europe Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
16.7.8. Rest of Europe Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17. Asia Pacific Global Liquid Biopsy Market
17.1. Asia Pacific Global Liquid Biopsy Market
17.1.1. Asia Pacific Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.1.2. Asia Pacific Liquid Biopsy Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
17.1.3. Asia Pacific Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
17.1.4. Asia Pacific Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
17.1.5. Asia Pacific Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
17.1.6. Asia Pacific Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
17.1.7. Asia Pacific Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
17.1.8. Asia Pacific Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
17.1.9. Asia Pacific Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17.2. Japan Global Liquid Biopsy Market
17.2.1. Japan Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.2.2. Japan Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
17.2.3. Japan Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
17.2.4. Japan Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
17.2.5. Japan Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
17.2.6. Japan Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
17.2.7. Japan Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
17.2.8. Japan Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17.3. China Global Liquid Biopsy Market
17.3.1. China Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.3.2. China Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
17.3.3. China Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
17.3.4. China Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
17.3.5. China Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
17.3.6. China Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
17.3.7. China Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
17.3.8. China Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17.4. India Global Liquid Biopsy Market
17.4.1. India Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.4.2. India Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
17.4.3. India Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
17.4.4. India Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
17.4.5. India Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
17.4.6. India Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
17.4.7. India Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
17.4.8. India Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17.5. South Korea Global Liquid Biopsy Market
17.5.1. South Korea Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.5.2. South Korea Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
17.5.3. South Korea Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
17.5.4. South Korea Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
17.5.5. South Korea Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
17.5.6. South Korea Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
17.5.7. South Korea Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
17.5.8. South Korea Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17.6. Australia Global Liquid Biopsy Market
17.6.1. Australia Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.6.2. Australia Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
17.6.3. Australia Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
17.6.4. Australia Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
17.6.5. Australia Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
17.6.6. Australia Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
17.6.7. Australia Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
17.6.8. Australia Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
17.7. Rest of Asia Pacific Global Liquid Biopsy Market
17.7.1. Rest of Asia Pacific Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
17.7.2. Rest of Asia Pacific Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
17.7.3. Rest of Asia Pacific Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
17.7.4. Rest of Asia Pacific Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
17.7.5. Rest of Asia Pacific Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
17.7.6. Rest of Asia Pacific Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
17.7.7. Rest of Asia Pacific Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
17.7.8. Rest of Asia Pacific Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
18. Latin America Global Liquid Biopsy Market
18.1. Latin America Global Liquid Biopsy Market
18.1.1. Latin America Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
18.1.2. Latin America Liquid Biopsy Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
18.1.3. Latin America Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
18.1.4. Latin America Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
18.1.5. Latin America Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
18.1.6. Latin America Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
18.1.7. Latin America Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
18.1.8. Latin America Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
18.1.9. Latin America Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
18.2. Brazil Global Liquid Biopsy Market
18.2.1. Brazil Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
18.2.2. Brazil Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
18.2.3. Brazil Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
18.2.4. Brazil Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
18.2.5. Brazil Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
18.2.6. Brazil Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
18.2.7. Brazil Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
18.2.8. Brazil Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
18.3. Mexico Global Liquid Biopsy Market
18.3.1. Mexico Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
18.3.2. Mexico Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
18.3.3. Mexico Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
18.3.4. Mexico Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
18.3.5. Mexico Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
18.3.6. Mexico Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
18.3.7. Mexico Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
18.3.8. Mexico Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
18.4. Argentina Global Liquid Biopsy Market
18.4.1. Argentina Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
18.4.2. Argentina Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
18.4.3. Argentina Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
18.4.4. Argentina Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
18.4.5. Argentina Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
18.4.6. Argentina Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
18.4.7. Argentina Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
18.4.8. Argentina Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
18.5. Rest of Latin America Global Liquid Biopsy Market
18.5.1. Rest of Latin America Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
18.5.2. Rest of Latin America Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
18.5.3. Rest of Latin America Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
18.5.4. Rest of Latin America Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
18.5.5. Rest of Latin America Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
18.5.6. Rest of Latin America Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
18.5.7. Rest of Latin America Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
18.5.8. Rest of Latin America Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
19. MEA Global Liquid Biopsy Market
19.1. MEA Global Liquid Biopsy Market
19.1.1. MEA Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
19.1.2. MEA Liquid Biopsy Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
19.1.3. MEA Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
19.1.4. MEA Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
19.1.5. MEA Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
19.1.6. MEA Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
19.1.7. MEA Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
19.1.8. MEA Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
19.1.9. MEA Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
19.2. GCC Global Liquid Biopsy Market
19.2.1. GCC Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
19.2.2. GCC Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
19.2.3. GCC Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
19.2.4. GCC Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
19.2.5. GCC Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
19.2.6. GCC Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
19.2.7. GCC Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
19.2.8. GCC Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
19.3. South Africa Global Liquid Biopsy Market
19.3.1. South Africa Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
19.3.2. South Africa Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
19.3.3. South Africa Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
19.3.4. South Africa Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
19.3.5. South Africa Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
19.3.6. South Africa Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
19.3.7. South Africa Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
19.3.8. South Africa Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
19.4. Rest of MEA Global Liquid Biopsy Market
19.4.1. Rest of MEA Liquid Biopsy Market Size and Forecast, 2023-2034 (Revenue USD Bn)
19.4.2. Rest of MEA Liquid Biopsy Market Size and Forecast, By Sample, 2023-2034 (Revenue USD Bn)
19.4.3. Rest of MEA Liquid Biopsy Market Size and Forecast, By Biomarker, 2023-2034 (Revenue USD Bn)
19.4.4. Rest of MEA Liquid Biopsy Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
19.4.5. Rest of MEA Liquid Biopsy Market Size and Forecast, By Technology, 2023-2034 (Revenue USD Bn)
19.4.6. Rest of MEA Liquid Biopsy Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
19.4.7. Rest of MEA Liquid Biopsy Market Size and Forecast, By Clinical Application, 2023-2034 (Revenue USD Bn)
19.4.8. Rest of MEA Liquid Biopsy Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
20. Competitor Analysis
20.1. Company Market Share Analysis, 2023
20.2. Major Recent Developments
21. Company Profiles
21.1. Biocept, Inc.
21.2. ANGLE plc
21.3. Oncimmune
21.4. Guardant Health, Inc.
21.5. Thermo Fisher Scientific, Inc.
21.6. Myriad Genetics, Inc.
21.7. QIAGEN
21.8. Freenome Holdings, Inc.
21.9. F. Hoffmann-La Roche Ltd.
21.10. Epigenomics AG
21.11. Lucence Health Inc.
21.12. Illumina, Inc.
21.13. Other Prominent Players
22. Conclusion23. Recommendations

Companies Mentioned

  • Biocept Inc.
  • ANGLE plc
  • Oncimmune
  • Guardant Health Inc.
  • Thermo Fisher Scientific Inc.
  • Myriad Genetics Inc.
  • QIAGEN
  • Freenome Holdings Inc.
  • F. Hoffmann-La Roche Ltd.
  • Epigenomics AG
  • Lucence Health Inc.
  • Illumina Inc.

Table Information